Vincerx Pharma, Inc. (VINC) DCF Valuation

Vincerx Pharma, Inc. (VINC) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Vincerx Pharma, Inc. (VINC) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Vincerx Pharma, Inc. (VINC) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Simplifique la valoración de Vincerx Pharma, Inc. (VINC) con esta calculadora DCF personalizable! Con el Real Vincerx Pharma, Inc. (VINC) Financials y las entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de Vincerx Pharma, Inc. (VINC) en minutos.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 -10.7 -62.7 -68.7 -42.6 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 5.7 .3 .9 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT .0 -16.4 -63.0 -69.6 -42.7 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .7 61.8 111.5 52.5 12.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 1.4 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 -1.2 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 .5 2.0 4.1 2.5 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 -5.3 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT .0 -16.4 -25.0 -60.9 -42.7 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .0 -10.3 -28.4 -58.0 -44.0 -2.5 .0 .0 .0 .0
WACC, % 8.17 8.17 7.16 7.96 8.17 7.93 7.93 7.93 7.93 7.93
PV UFCF
SUM PV UFCF -2.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -10
Equity Value 8
Diluted Shares Outstanding, MM 21
Equity Value Per Share 0.37

What You Will Receive

  • Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-filled real VINC financials.
  • Accurate Data: Access to historical data and forward-looking estimates (highlighted in the yellow cells).
  • Flexible Forecasting: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Instant Calculations: Quickly observe how your inputs affect Vincerx Pharma’s valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Centric Layout: Organized for clarity and ease of use, complete with step-by-step guidance.

Key Features

  • 🔍 Real-Life VINC Financials: Pre-filled historical and projected data for Vincerx Pharma, Inc. (VINC).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Vincerx's intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Vincerx's valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file for Vincerx Pharma, Inc. (VINC).
  2. Step 2: Review Vincerx Pharma’s pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Analyze the outputs and leverage the results for your investment decisions.

Why Choose This Calculator for Vincerx Pharma, Inc. (VINC)?

  • User-Friendly Interface: Tailored for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters to suit your specific analysis needs.
  • Real-Time Feedback: Instantly observe changes in Vincerx Pharma’s valuation as you tweak inputs.
  • Preloaded Data: Comes equipped with Vincerx Pharma’s actual financial metrics for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making educated choices.

Who Should Use This Product?

  • Investors: Accurately assess Vincerx Pharma’s fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to Vincerx Pharma (VINC).
  • Consultants: Quickly tailor the template for valuation reports focused on Vincerx Pharma (VINC) for clients.
  • Entrepreneurs: Acquire insights into financial modeling practices utilized by leading pharmaceutical companies.
  • Educators: Employ it as a teaching resource to illustrate valuation methodologies applicable to the biotech sector.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations specific to Vincerx Pharma, Inc. (VINC).
  • Real-World Data: Vincerx Pharma’s historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
  • Financial Statements: Full annual and quarterly breakdowns for deeper insights into Vincerx Pharma's performance.
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage tailored to Vincerx Pharma, Inc. (VINC).
  • Dashboard with Visual Outputs: Charts and tables for clear, actionable results related to Vincerx Pharma, Inc. (VINC).

No products were found matching.